CWM
IBRX icon

CIBC World Markets’s ImmunityBio IBRX Stock Holding History

CIBC World Markets’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$38.7K Buy
+19,525
New +$44.2K ﹤0.01% 1207
2025
Q2 		$74.8K Sell
28,343
-5,569
-16% -$15K ﹤0.01% 1433
2025
Q1 		$102K Buy
33,912
+20,366
+150% +$61.7K ﹤0.01% 1596
2024
Q4 		$34.7K Buy
+13,546
New +$56.4K ﹤0.01% 1287

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

CIBC World Markets's IBRX Position: Q4 2025 in Review

CIBC World Markets opened a new position in ImmunityBio (IBRX) in Q4 2025: 19,525 shares worth $38.7K. The stake represents ﹤0.01% of the portfolio and ranks #1207 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in IBRX as recently as Q2 2025.

CIBC World Markets first reported a position in IBRX in Q4 2024 and has held it in 4 quarters since. The position peaked at $102K in Q1 2025. 276 funds tracked by Wall St. Rank hold IBRX as of Q4 2025.

  • CIBC World Markets held 19,525 shares of ImmunityBio worth $38.7K as of Q4 2025.
  • ImmunityBio was a new CIBC World Markets position in Q4 2025.
  • ImmunityBio made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1207 holding.
  • CIBC World Markets first reported a position in ImmunityBio in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's ImmunityBio position peaked at $102K in Q1 2025.
  • 276 funds tracked by Wall St. Rank held ImmunityBio as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.